Lipton SA - Search Results

1

Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.

Seki M, Lipton SA. Seki M, et al. Among authors: lipton sa. Prog Brain Res. 2008;173:495-510. doi: 10.1016/S0079-6123(08)01134-5. Prog Brain Res. 2008. PMID: 18929130 Review.

2

Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons.

Budd SL, Tenneti L, Lishnak T, Lipton SA. Budd SL, et al. Among authors: lipton sa. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6161-6. doi: 10.1073/pnas.100121097. Proc Natl Acad Sci U S A. 2000. PMID: 10811898 Free PMC article.

3

Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells.

Kikuchi M, Tenneti L, Lipton SA. Kikuchi M, et al. Among authors: lipton sa. J Neurosci. 2000 Jul 1;20(13):5037-44. doi: 10.1523/JNEUROSCI.20-13-05037.2000. J Neurosci. 2000. PMID: 10864961 Free PMC article.

4

Retinal ganglion cells, glaucoma and neuroprotection.

Lipton SA. Lipton SA. Prog Brain Res. 2001;131:712-8. Prog Brain Res. 2001. PMID: 11420983 Review. No abstract available.

5

Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina.

Manabe S, Lipton SA. Manabe S, et al. Among authors: lipton sa. Invest Ophthalmol Vis Sci. 2003 Jan;44(1):385-92. doi: 10.1167/iovs.02-0187. Invest Ophthalmol Vis Sci. 2003. PMID: 12506100

6

Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage.

Lipton SA. Lipton SA. Surv Ophthalmol. 2003 Apr;48 Suppl 1:S38-46. doi: 10.1016/s0039-6257(03)00008-0. Surv Ophthalmol. 2003. PMID: 12852433 Review.

7

Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type 1-associated dementia: Chemokine receptors, excitotoxicity, and beyond.

Kaul M, Lipton SA. Kaul M, et al. Among authors: lipton sa. J Neurovirol. 2004;10 Suppl 1:97-101. doi: 10.1080/753312759. J Neurovirol. 2004. PMID: 14982746 Review.

8

Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.

Lipton SA. Lipton SA. J Alzheimers Dis. 2004 Dec;6(6 Suppl):S61-74. doi: 10.3233/jad-2004-6s610. J Alzheimers Dis. 2004. PMID: 15665416

9

Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.

Lipton SA. Lipton SA. NeuroRx. 2004 Jan;1(1):101-10. doi: 10.1602/neurorx.1.1.101. NeuroRx. 2004. PMID: 15717010 Free PMC article. Review.

10

Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels.

Chen HS, Lipton SA. Chen HS, et al. Among authors: lipton sa. J Pharmacol Exp Ther. 2005 Sep;314(3):961-71. doi: 10.1124/jpet.105.085142. Epub 2005 May 18. J Pharmacol Exp Ther. 2005. PMID: 15901795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters